Cart
sales@molnova.com
TRPM4 inhibitor 8
CAS No. 1353979-43-7
TRPM4 inhibitor 8 ( —— )
Catalog No. M28894 CAS No. 1353979-43-7
TRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | Get Quote |
|
| 10MG | 53 | Get Quote |
|
| 25MG | 87 | Get Quote |
|
| 50MG | 170 | Get Quote |
|
| 100MG | 267 | Get Quote |
|
| 200MG | 402 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTRPM4 inhibitor 8
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion.
-
DescriptionTRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorEndothelin A receptor;Endothelin B receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1353979-43-7
-
Formula Weight257.2
-
Molecular FormulaC11H17BrN2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(CCN)Cc1cccc(Br)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Balwierczak JL, et al. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500.J Cardiovasc Pharmacol. 1995;26 Suppl 3:S393-6.
molnova catalog
related products
-
JNJ-38893777
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
Vitexin
Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
-
SB-705498
A potent, selective and orally bioavailable TRPV1 antagonist with pKi of 7.6 (inhibition of capsaicin-mediated activation of hTRPV1 receptor).
